Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies

Chimeric antigen receptor (CAR) T-cell therapy has greatly transformed the treatment and prognosis of B-cell hematological malignancies. As CAR T-cell therapy continues to be more readily adopted and indications increase, the field’s recognition of emerging toxicities will continue to grow. Among th...

Descripción completa

Detalles Bibliográficos
Autores principales: Schorr, Christopher, Forindez, Jorge, Espinoza-Gutarra, Manuel, Mehta, Rakesh, Grover, Natalie, Perna, Fabiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179014/
https://www.ncbi.nlm.nih.gov/pubmed/37176053
http://dx.doi.org/10.3390/ijms24098349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179014/
https://www.ncbi.nlm.nih.gov/pubmed/37176053
http://dx.doi.org/10.3390/ijms24098349

Ejemplares similares